Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 43 | 42 | −1 |
| Shares | 1.93M | 1.98M | +43.3K (+2.2%) |
| Value | $17.1M | $11.5M | −$5.65M (−32.9%) |
New holders (9)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 14,020 | $84.0K | 0.01% |
| Spire Wealth Management | 1,800 | $11.0K | 0.00% |
| CWM, LLC | 1,622 | $10.0K | 0.00% |
| Group One Trading, L.P. | 1,063 | $6.00K | 0.00% |
| Captrust Financial Advisors | 1,000 | $6.00K | 0.00% |
| National Bank of Canada | 855 | $5.00K | 0.00% |
| Trust Co of Vermont | 50 | $0 | 0.00% |
| Endurant Capital Management LP | 66,666 | $0 | 0.00% |
| Dixon Hughes Goodman Wealth Advisors LLC | 33 | $0 | 0.00% |
Sold out (10)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace, LLP | 22,469 | $199.0K |
| ExodusPoint Capital Management, LP | 17,800 | $158.0K |
| Interchange Capital Partners, LLC | 16,420 | $145.0K |
| Wealthspire Advisors, LLC | 14,348 | $127.0K |
| BIT Capital GmbH | 14,100 | $124.9K |
| Citadel Advisors LLC | 11,001 | $98.0K |
| Total Clarity Wealth Management, Inc. | 500 | $4.00K |
| Glassman Wealth Services | 200 | $2.00K |
| Tarbox Family Office, Inc. | 66 | $1.00K |
| Glen Eagle Advisors, LLC | 6 | $53 |